Release Date: July 1, 2017
Expiration Date: July 1, 2018
David P. Carbone, MD, PhD
Barbara J. Bonner Chair in Lung Cancer Research
Director, James Thoracic Center
Professor of Medicine
The Ohio State University Comprehensive Cancer Center
Edward S. Kim, MD
Chair, Department of Solid Tumor Oncology and Investigational Therapeutics
Donald S. Kim Distinguished Chair for Cancer Research
Levine Cancer Institute, Carolinas HealthCare System
Charlotte, North Carolina
The goal of this activity is to educate health care professionals about improving outcomes in patients with non-small cell lung cancer (NSCLC).
At the completion of this activity, participants should be better able to:
- Summarize genetic and immune targets relevant to NSCLC treatment
- Compare mutation analysis technologies used in NSCLC
- Describe opportunities and challenges associated with traditional tissue biopsy and liquid biopsy for molecular testing in NSCLC
- Review clinical trials investigating the safety and efficacy of available agents targeting genetic aberrations and immune checkpoints in NSCLC
- Explain how to communicate effectively with patients and caregivers to overcome misconceptions about NSCLC, optimize outcomes, and enhance clinical trial participation
Providers who care for patients with NSCLC, including oncologists, oncology nurses, and specialty pharmacists
Estimated Time for Completion
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Applied Clinical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
To receive CME credit, participants should read the monograph and complete the pre-test, post-test, and activity evaluation at www.cmezone.com/CU171.
CME certificates will be made available immediately upon successful completion.
Disclosure of Conflicts of Interest
Global Education Group requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest they may have as related to the content of this activity. All identified conflicts of interest are vetted thoroughly by Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:
- David P. Carbone, MD, PhD: Ariad, AstraZeneca, Bayer Health Care, Biocept, Biothera, Boehringer Ingelheim, Bristol Myers-Squibb, Cancer Support Community, Clovis Oncology, Genentech/Roche, Guardant Health, Inivata, Janssen Diagnostics, Merck, Novartis, Peregrine Pharmaceuticals, Pfizer, Synta Pharmaceuticals (consultant)
- Edward S. Kim, MD: AstraZeneca, Boehringer Ingelheim, Celgene, Eli Lilly and Company (consultant/independent contractor)
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:
- Jennifer Kulpa: Nothing to disclose
- Kathleen Wildasin: Nothing to disclose
- Andrea Funk: Nothing to disclose
- Ashley Marostica, Lindsay Knight, Jamie Patrick: Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Applied Clinical Education do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or courses of diagnosis or treatment discussed should not be used by clinicians without evaluation of patient conditions, contraindications, applicable manufacturer’s product information, and the recommendations of other authorities.
Accreditor Contact Information
For information about the accreditation of this program, please contact Global Education Group at (303) 395-1782 or email@example.com
- Operating system: Windows or Macintosh
- Media viewing requirements: Flash Player or Adobe Reader
- Supported browsers: Microsoft Internet Explorer, Firefox, Google Chrome, Safari, and Opera
- A good Internet connection